Orthofix Sales Accelerated Late in First Quarter

Orthofix reported 1Q22 orthopedic sales of $106.4 million, +0.8% vs. 1Q21. The company experienced a significant slowdown in procedure volume due to COVID restrictions and hospital staffing shortages, but March brought a strong recovery.  A low-single-digit decline in complex spine procedures in the first quarter slowed growth, but was...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us